Drawing for DESIGNED TO DELIVER

USPTO serial 97789883

DESIGNED TO DELIVER

Reviewed by CopyMark Law Group

Reg. 7553331Status 700Registered
Filing date
Status date
Registration date
Oct 29, 2024
Examiner
GULIANO, ROBERT N
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DESIGNED TO DELIVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David W. Staple

David W. Staple CASIMIR JONES, S.C.2275 DEMING WAY, SUITE 310MIDDLETON, WI 53562United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations containing immune globulin for the treatment of immune system, infectious disease, and pulmonary diseases and disorders; pharmaceutical preparations containing plasma protein therapeutics for the treatment of immune system, infectious disease, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious disease; pharmaceutical preparations for the treatment and prevention of pulmonary disease; pharmaceutical preparations for administration to an immunocompromised subject for the treatment of immune system, infectious disease, and pulmonary diseases and disordersACTIVEJun 10, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 29, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 23, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 18, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 18, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 16, 2024IUAFUSE AMENDMENT FILED—
Jul 16, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2023DOCKASSIGNED TO EXAMINER—
Mar 1, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance